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QABSTRACT
Objectives: To investigate the potential beneficial effects of posterior pericardial
drainage in patients undergoing heart surgery.
Methods: Multiple online databases and relevant congress proceedings were
screened for randomized controlled trials assessing the efficacy and safety of
posterior pericardial drainage, defined as posterior pericardiotomy incision,
chest tube to posterior pericardium, or both. Primary endpoint was in-hospital/
30 days’ cardiac tamponade. Secondary endpoints comprised death or
cardiac arrest, early and late pericardial effusion, postoperative atrial fibrillation
(POAF), acute kidney injury, pulmonary complications, and length of hospital
stay.
Results: Nineteen randomized controlled trials that enrolled 3425 patients were
included. Posterior pericardial drainage was associated with a significant 90%
reduction of the odds of cardiac tamponade compared with the control group:
odds ratio (95% confidence interval) 0.13 (0.07-0.25); P < .001. The
corresponding event rates were 0.42% versus 4.95%. The odds of early and
late pericardial effusion were reduced significantly in the intervention arm:
0.20 (0.11-0.36); P<.001 and 0.05 (0.02-0.10); P<.001, respectively. Posterior
pericardial drainage significantly reduced the odds of POAF by 58% (P<.001)
and was associated with significantly shortened (by nearly 1 day) overall length
of hospital stay (P<.001). Reductions in postoperative complications translated
into significantly reduced odds of death or cardiac arrest (P ¼ .03) and
numerically lower odds of acute kidney injury (P ¼ .08).
Conclusions: Posterior pericardial drainage is safe and simple technique that
significantly reduces not only the prevalence of early pericardial effusion and
POAF but also late pericardial effusion and cardiac tamponade. These benefits,
in turn, translate into improved survival after heart surgery. (J Thorac Cardiovasc
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The Journal of Thoracic and Cardiovascular SPericardial effusion often leads to delayed cardiac
tamponade after heart surgery.1
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Posterior pericardial drainage was found to
reduce postoperative complications, such as
cardiac tamponade and atrial fibrillation,
among others. In addition, it improved survival
after heart surgery.Perspective
Pericardial effusion may be a source of
morbidity after heart surgeries. Posterior peri-
cardial drainage allows free escape of the fluid
to the pleural space or on the outside via chest
tubes. Previous studies showed that by reducing
the amount of pericardial effusion, one can
avoid postoperative atrial arrhythmias; whether
other postoperative complications may be
reduced remains unresolved.Despite several recent improvements in intraoperative man-
agement and postoperative care, pericardial effusion re-
mains a common clinical problem after cardiac surgeryand may represent an important cause of morbidity.1,2
Although limited pericardial effusion usually does not
need any treatment (it is self-limiting and an incidentalept 6, 2016; revisions received Nov 7, 2016; accepted for
6.
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VIDEO 1. Posterior pericardiotomy procedure. The ‘‘inverse T’’ incision
is performed by the end of the surgical procedure to the posterior aspect of
the pericardium. Attention is given not to dissect the phrenic nerve (to the
right from the incision site) and that any bleeding vessels from the pericar-
diotomy site are clipped or meticulously cauterized. Video available at:
http://www.jtcvs.org.
Abbreviations and Acronyms
AKI ¼ acute kidney injury
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
POAF ¼ postoperative atrial fibrillation
PP ¼ posterior pericardiotomy
OR ¼ odds ratio
RCT ¼ randomized controlled trial
Scanning this QR code will take
you to supplemental figures,
tables, and a procedural video.
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Qfinding during control echocardiography or computed to-
mography), large effusion may prolong recovery and be
life-threatening in case of cardiac tamponade with hemody-
namic compromise and/or multiorgan failure.3 The reported
incidence of postoperative pericardial effusion ranges
between 1% and 85%, depending on study definitions
and designs.4-6
In the majority of heart surgery procedures, the pericar-
dium usually is opened longitudinally, because this allows
free access to the heart and proximal great vessels. At the
end of the procedure, the pericardium usually is left open,
although some surgeons choose to close it, except for a
small portion at the most caudal part. A second, or auxiliary,
incision in the posterior pericardium (Video 1) sometimes is
used to facilitate drainage of blood into the pleural cavity,
where it can be evacuated with chest tubes. This technique
has been shown in nonrandomized trials to reduce the inci-
dence of both postoperative pericardial effusion and postop-
erative supraventricular tachycardia,7 suggesting that a
large volume of pericardial effusion is one of the main trig-
gers of atrial fibrillation after cardiac surgery.8
The 2005 American College of Chest Physicians and
subsequent 2006 European Association for Cardiothoracic
Surgery Guidelines recommended that posterior pericar-
diotomy (PP) may be a useful, small step to reduce the
incidence of postoperative atrial arrhythmias9,10; however,
this recommendation was based on a single, small-scale
randomized controlled trial11 (RCT; strength of recommen-
dation, B; evidence grade, fair; net benefit, intermediate).
PP is not a current standard of care thus far and it is not
used widely.
Because of the moderate strength of the recommenda-
tions, and because more RCTs that assess safety and
efficacy of posterior pericardial drainage have been
available since 2006, we performed a systematic review2 The Journal of Thoracic and Cardiovascular Surgerand meta-analysis to investigate whether potential reduc-
tion of pericardial effusion and atrial arrhythmias may
affect positively the incidence of other potentially life-
threatening conditions.METHODS
Data Sources and Search Strategy
This current systematic review and meta-analysis was performed in
accordance with the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses statement meta-analyses in health care interventions12;
the checklist is available as Table E1. Relevant RCTs to be included were
searched until March 2016 through PubMed, EMBASE, CINAHL, the
Web of Science, the Cochrane Register of Controlled Clinical Trials (ie,
CENTRAL), and Google Scholar as well as congress proceedings from
major cardiac, thoracic, and cardiothoracic, as well as cardiology societies
meetings. An exemplary PubMed search strategy is attached as Table E2.
Abstracts were eligible for detailed assessment if available online and
reporting outcomes of interest. Search terms were: ‘‘pericardiotomy,’’
‘‘pericardial incision,’’ ‘‘pericardial window,’’ ‘‘posterior pericardiotomy,’’
‘‘pericardial drainage,’’ ‘‘posterior pericardium drainage,’’ ‘‘posterior
pericardial chest tube,’’ ‘‘additional chest tube,’’ ‘‘randomized,’’ and
‘‘study/trial.’’ No language restrictions were imposed. Both blinded and
open-label trials were considered eligible. The most updated or inclusive
data for each study were used for abstraction. References of original
articles and previous meta-analyses were reviewed manually and cross-
checked.
Selection Criteria, Quality Assessment, and
Outcomes
Studies were included if they met all of the following criteria: (1) RCT;
(2) human study; (3) study comparing strategy of posterior pericardial
drainage with no intervention to the pericardium during heart surgery;
and (4) studies reporting outcomes of interest within the investigated
follow-up. Studies were only excluded if they (1) were nonrandomized
or (2) had no control group. Narrative reviews, case reports, letters to the
editor, etc, were not considered.
Posterior pericardial drainage was defined as (1) PP incision allowing
drainage of the pericardial blood/effusion into the pleural cavity; (2) inser-
tion of a chest tube in the posterior pericardium or; (3) both PP and insertiony c- 2017
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Qof a chest tube in the pericardium. Patients in the control group underwent
no intervention to the posterior pericardium.
Two independent reviewers (M.G. andM.K.) selected the studies for the
inclusion and extracted studies and patients characteristics of interest and
relevant outcomes. Two authors (M.G. and M.K.) independently assessed
the trials’ eligibility and risk of bias. Any divergences relative to study in-
clusion/exclusion or bias assessment were resolved after discussion with
the third reviewer (L.A.). The bias risk for randomized studies was assessed
by use of the components recommended by the Cochrane Collaboration,13
ie, random sequence generation and random allocation; allocation
concealment; blinding of participants, personnel, and outcome assessors;
incomplete outcome data; selective outcome reporting; and other sources
of bias. The discrepancies in bias assessment between assessors were re-
corded and reported as Cohen’s kappa.14
Endpoints Selection
Primary clinical outcome was in-hospital/30 days’ cardiac tamponade
defined according to study protocol; remaining outcomes assessed were
in-hospital/30 days: death or cardiac arrest; early and late pericardial effu-
sion; postoperative atrial fibrillation (POAF); total chest drainage volume;
pleural effusion with or without intervention; reoperation for bleeding;
acute kidney injury (AKI); pulmonary complications; and length of inten-
sive care unit and hospital stay. Late pleural effusion could have occurred
beyond the investigated follow-up.
Statistical Analysis
Data were analyzed according to intention-to-treat principle wherever
applicable. Odds ratios (ORs) and 95% confidence intervals (CIs)
served as primary index statistics for dichotomous outcomes; for contin-
uous outcomes, mean difference and corresponding 95% CIs were
calculated by the use of a random effects model. To overcome the
low statistical power of Cochran Q test, the statistical inconsistency
test I2 ¼ [(Q  df)/Q] 3 100%, where Q is the c2 statistic and df
its degrees of freedom, was used to assess heterogeneity.15 It examines
the percentage of interstudy variation, with values ranging from 0% to
100%. An I2 value less than 40% indicated no obvious heterogeneity,
values between 40% and 70% were suggestive of moderate heterogene-
ity, and I2> 70% were considered high heterogeneity.
Pooled ORs were calculated via the Mantel-Haenszel model with
weight assigned to each included study adjusted to include a measure of
variation (t2) in the effects reported between studies. This approach esti-
mates the amount of between-study variation by comparing each study’s
result with a Mantel-Haenszel fixed-effect meta-analysis result and is
most conservative in case of low between study heterogeneity.16 In case
the degree of heterogeneity exceeded 40%, an inverse variance (DerSimo-
nian-Laird) random-effects model was applied. As a preferred approach
when intervention effects are small (ORs are close to one) and events are
not particularly common, estimates were calculated by the use of the
fixed-effects Peto method.17 In case there were ‘‘0 events’’ reported in
both arms, calculations were repeated, as a sensitivity analysis, by the
use of risk difference and respective 95% CIs.
Furthermore, an attempt was made to explore the possible relationship
between age, sex, hypertension, type 2 diabetes, type of the surgery, mean
number of grafts, duration of cardiopulmonary bypass, crossclamp, and
study total number of patients and the occurrence of primary endpoint. De-
pending on availability of the data, studies were dichotomized separately
by these characteristics. The cutoff points were made so as to have equal,
or nearly equal, numbers of studies on each side of the dichotomy. Pooled
ORs were obtained for each subset of studies and combined in a random-
effect meta-analysis. As a sensitivity analysis, the calculations were
repeated stratified by the operative technique and after deleting studies,
one in a turn, to see whether the results for the primary endpoint were
not influenced by single report. In addition, studies not reporting the exactThe Journal of Thoracic and Cdefinition/diagnostic criteria for the primary endpoint also were excluded
in the sensitivity analysis and estimates recalculated.
Potential publication bias was evaluated by constructing a funnel plot in
which the standard error of the log OR was plotted against the OR. The
asymmetry of the plot was estimated both visually and by a linear regres-
sion approach.18 Review Manager V.5.1 (The Nordic Cochrane Centre,
København, Denmark) and Comprehensive Meta-Analysis, v. 2 (Biostat,
Englewood, NJ) were used for statistical computations. P values .05
were considered statistically significant and reported as 2-sided, without
adjustment for multiple comparisons.RESULTS
Study Selection
The study selection process and reasons for exclusion of
some studies are described in Figure 1. A systematic search
of the online databases allowed us to collect 37 potentially
eligible records that were retrieved for scrutiny. Of those,
18 were further excluded because they were not pertinent
to the design of the meta-analysis or did not meet the explicit
inclusion criteria. Nineteen RCTs11,19-37 that enrolled 3425
patients eventually were included in the analysis. Patients
were divided into 2 groups: those with a posterior
pericardial drainage (n ¼ 1723) and control group without
(n ¼ 1702). In the group of patients who received a
posterior pericardial drainage, 1447 patients underwent
PP11,19-26,28-30,33-37; in 103 patients, a chest tube was
placed within the posterior pericardium27,30; 173 patients
received both PP and posterior pericardium chest tube.31,32
On-pump coronary artery bypass grafting (CABG)
was the most frequently performed cardiac
procedure,11,19,20,23,25,28,30-36 followed by combined CABG
and/or valve replacement.21,22,24,37 Two studies reported on
patients undergoing valve replacement and/or ascending
aorta surgery26,27 and another on patients who received off-
pump CABG alone.29 Summaries of the studies, as well as
patients’ baseline characteristics, are reported in Table 1.
Table E3 lists exclusion criteria within single studies; these
were predominantly renal dysfunction, endocrine disorders,
severe left ventricle dysfunction, history of arrhythmias, and
previous cardiac surgery. Definitions or diagnostic criteria
for assessed clinical endpoints are listed in Table E4.
Inmost studies, 2 drains were placed at the end of surgery:
one in the left pleural cavity and the other in the anterior
mediastinum, whereas the pericardium was left open anteri-
orly. PP was performed as described by Mulay and col-
leagues38 and comprised a longitudinal, 4-cm long
incision parallel and posterior to the phrenic nerve,
extending from left inferior pulmonary vein to the
diaphragm in most cases.11,19-26,28-32,35,36 A detailed
technique is reported in Table E5. Table E6 includes an anal-
ysis of potential sources of bias for randomized studies using
the components recommended by the Cochrane Collabora-
tion. Further publication bias as assessed by funnel plots
for the investigated endpoints is shown in Figure E1, A to
H. Two of the included studies reported intervention-ardiovascular Surgery c Volume-, Number- 3
FIGURE 1. Flowdiagramaccording to PreferredReporting Items for SystematicReviews andMeta-Analyses guidelines.RCT, Randomizedcontrolled trial.
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Qrelated complications: Zhao and colleagues37 reported one
case of postoperative bleeding due to dropping of the hemo-
clip from the inverse-T incision and Farsak and colleagues11
reported one case of re-exploration of the grafts because of
hemodynamic instability and uncontrollable arrhythmia.
The reason was found to be attributable to a protruding
sequential vein graft from the pericardiotomy side.Primary Endpoint
A funnel plot constructed for the primary endpoint re-
vealed signs of moderate asymmetry (Figure E1, A), but
this was not significant (Egger test, P ¼ .11). Fourteen
studies (n ¼ 2844) were included. Individual and overall
ORs for cardiac tamponade are depicted in Figure 2. Poste-
rior pericardial drainage was associated with a significant
approximately 90% reduction of the odds of cardiac tampo-
nade compared with the control group: OR (95% CI) 0.13
(0.07-0.25); P<.001; I2 ¼ 0% in the fixed-effects model.4 The Journal of Thoracic and Cardiovascular SurgerThe corresponding event rates were 0.42% (6/1431) versus
4.95% (70/1413).Death or Cardiac Arrest
No asymmetry, thus, no signs of publication bias, was
noted in the analysis of death or cardiac arrest (Figure E1,
B). Ten RCTs enrolling 2141 patients provided data for
the analysis. The ORs of death or cardiac arrest were
significantly decreased by roughly 50% in the posterior
pericardial drainage group compared with controls: Peto
OR (95% CI): 0.49 (0.25-0.94); P ¼ .03; I2 ¼ 0%. There
were 12 deaths (1.11%) or cardiac arrests compared with
24 (2.26%), respectively, in the posterior pericardial
drainage and control groups (Figure 3).Early and Late Pericardial Effusion
Figure 4 lists individual and overall ORs for early
(Figure 4, A) and late (Figure 4, B) pericardial effusiony c- 2017
TABLE 1. Baseline characteristics of included studies
Study Setting Intervention
No.
patients
Mean
age, y
Male
(%) CPB, min
Crossclamp,
min HT,% DM,%
Mean no.
grafts
Arbatli and
colleagues19
CABG Posterior pericardiotomy 54 62  8 83 117  32 58  17 61 26 2.9  0.9
Control 59 60  9 74 112  35 60  19 59 26 2.9  0.9
Asimakopoulos and
colleagues20
CABG Posterior pericardiotomy 50 61  9 nd 66  17 35  2 20 20 2.7  0.6
Control 50 61  2 nd 62  17 33  8 38 10 2.7  0.7
Bakhshandeh and
colleagues21,22
CABG Posterior pericardiotomy 205 67  8 38 NR NR 55 40 3.2  0.9
Valve
replacement
Control 205 68  9 42 46 47 3.3  0.7
Bolourian and
colleagues23
CABG Posterior pericardiotomy 87 60  11 71 95  38 56  24 47 NR 3.4  0.7
Control 87 60  10 71 94  38 54  22 47 3.1  0.9
Cakalagaoglu and
colleagues24
CABG Posterior pericardiotomy 50 63  8 80 92  22 55  19 68 28 2.8  0.9
Valve
replacement
Control 50 59  13 86 88  38 53  30 62 30 2.5  0.75
Ekim and
colleagues25
CABG Posterior pericardiotomy 50 59  9 66 89  21 63  19 52 20 2.8  0.4
Control 50 60  3 64 87  26 62  12 48 22 2.7  0.9
Erdil and
colleagues26
Valve
replacement
Posterior pericardiotomy 50 41  14 46 114  51 86  40 NR NR NA
Ascending
aorta surgery
Control 50 43  15 32 115  44 86  37
Eryilmaz and
colleagues27
Valve
replacement
Additional chest tube 70 55  7 41 171  22 NR NR NR NA
Ascending aorta
surgery
Control 70 56  7 46 176  19
Farsak and
colleagues11
CABG Posterior pericardiotomy 75 64  9 36 57  6 35  11 41 17 NR
Control 75 63  5 32 61  9 40  9 36 15
Fawzy and
colleagues28
CABG Posterior pericardiotomy 100 54  9 64 89  29 55  21 56 48 2.7  0.6
Control 100 56  10 68 87  23 59  17 54 46 2.6  0.4
Haddadzadeh and
colleagues29
OPCAB Posterior pericardiotomy 105 61  10 69 NA NA 55 41 2.1  0.7
Control 102 61  11 69 44 31 2.1  0.7
Kaya and
colleagues30
CABG Posterior pericardiotomy 30 60  10 77 80  26 43  16 50 53 3.37  1.19
Additional chest tube 33 59  8 76 82  21 43  15 70 61 3.18  0.85
Control 33 59  11 88 86  27 46  21 55 36 3.0  0.90
Kaya and
colleagues31
CABG Posterior pericardiotomy þ
additional chest tube
70 58  9 86 78  20 44  13 44 56 3.33  0.94
Control 72 56  9 81 80  23 45  13 40 57 3.15  0.69
Kaya and
colleagues32
CABG Posterior pericardiotomy þ
additional chest tube
103 58  9 78 82  26 45  19 47 47 3.01  1.08
Control 107 57  9 79 77  23 43  15 38 53 2.88  0.85
Kaygin and
colleagues33
CABG Posterior pericardiotomy 213 59  11 50 NR NR NR 55 NR
Control 212 59  11 50 56
Kongmalai and
colleagues34
CABG Posterior pericardiotomy 10 65  13 nd 128  49 84  38 NR NR NR
Control 10 59  5 nd 152  45 107  39
Kuralay and
colleagues35
CABG Posterior pericardiotomy 100 57  12 77 48  5 36  12 NR NR 2.8  0.8
Control 100 61  8 73 51  4 43  9 3.1  0.5
Sadeghpour and
colleagues36
CABG Posterior pericardiotomy 40 61  8 78 NR NR NR 65 3.2  0.7
Control 40 60  13 80 37 3.5  1.5
Zhao and
colleagues37
CABG Posterior pericardiotomy 228 54  16 60 110  46 67  29 41 43 NR
Valve
replacement
Control 230 56  18 54 103  51 62  23 39 47
CPB, Cardiopulmonary bypass; crossclamp, aortic cross clamp;HT, hypertension;DM, diabetes mellitus; CABG, coronary artery bypass grafting; nd, not done; NR, not reported;
NA, not applicable; OPCAB, off-pump coronary artery bypass.
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Qwithin the investigated comparison. Sixteen studies (3009
patients) were included in the analysis of early pericardial
effusion: posterior pericardial drainage was associated
with 80% reduction of the odds of early effusion: 0.20The Journal of Thoracic and C(0.11-0.36); P<.001; I2 ¼ 71%. Early pericardial effusion
occurred in 6.2% (94/1516) of the patients who received a
posterior pericardial drainage compared with 23.38%
(249/1493) in the control group. Even a greater protectiveardiovascular Surgery c Volume-, Number- 5
FIGURE 2. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for prevention of primary endpoint car-
diac tamponade after heart surgery. M-H, Mantel-Haenszel; CI, confidence interval.
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analysis of late pericardial effusion: only 5 patients
(0.51%) in the intervention group were diagnosed with
late pericardial effusion compared with 121 patients
(12.82%) in the control group (OR [95% CI]: 0.05
[0.02-0.10]; P<.001; I2 ¼ 0%).
Postoperative Atrial Fibrillation
Incidence of POAF was reported in 17 RCTs enrolling
3245 patients. Individual and overall ORs are depicted in
Figure 5. Posterior pericardial drainage significantly
reduced the odds of POAF by 58%: 0.42 (0.29-0.59);
P<.001; I2 ¼ 66%. The incidence of POAF ranged from
12.55% (205/1633) to 24.81% (400/1612) in the group of
patients who received a posterior pericardial drainage and
in those who did not, respectively.
Posterior pericardial drainage did not increase signifi-
cantly the volume of total chest tube drainage (meanFIGURE 3. Forest plot of the comparison between posterior pericardial draina
after heart surgery. CI, Confidence interval.
6 The Journal of Thoracic and Cardiovascular Surgerdifference [95% CI]: 24.85 [21.48 to 71.17] mL;
P ¼ .29; I2 ¼ 91%; Figure E2) but was associated with a
64% increase in the OR of pleural effusion managed with
or without intervention: OR (95% CI): 1.64 (1.27-2.13);
P<.001; I2 ¼ 1%; and reported in 18.56% and 12.35%
of cases in posterior pericardial drainage and control
groups, respectively (Figure E3), although there was no dif-
ference between posterior pericardial drainage and usual
drainage with regard to pulmonary complications: 0.89
(0.65-1.23); P ¼ .48; I2 ¼ 0% (Figure E4). Similarly, no
differences were observed in the incidence of reoperations
for bleeding (3.50% [36/1028] vs 4.16% [42/1008]): 0.83
(0.53-1.30); P ¼ .42; I2 ¼ 0% (Figure E5).
Analysis of studies with a focus to the incidence of AKI
(4 studies; 816 patients) showed that posterior pericardial
drainage compared with the control group was associated
with a statistical trend favoring the intervention: Peto OR
(95% CI): 0.41 (0.15-1.10); P ¼ .08; I2 ¼ 5%. Respectivege (intervention) and control group for prevention of death or cardiac arrest
y c- 2017
FIGURE 4. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for prevention of early (A) and late (B)
pericardial effusion after heart surgery. IV, Inverse variance; CI, confidence interval; M-H, Mantel-Haenszel.
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(Figure E6).
In addition, although the length of stay in the intensive
care unit was not significantly different with either
approach (mean difference [95% CI]: 0.03 [0.21 to
0.28] days; P¼ .80; I2¼ 64% [Figure E7, A]), a significant
reduction of nearly 1 day was observed when the overall
length of hospital stay was investigated: 0.82 (1.12 to
0.51) days; P<.001; I2 ¼ 57% (Figure E7, B).
Sensitivity Analyses
In a prespecified subgroup analysis, calculations repeated
for the primary endpoint stratified by study/patients’ base-
line characteristics confirmed the consistency of the effect
of posterior pericardial drainage throughout different pa-
tient populations, study designs, and operativeThe Journal of Thoracic and Ccharacteristics. P values for interaction ranged from .20 to
.79 (Figure 6). Calculations repeated for the primary
endpoint after we accounted for studies reporting ‘‘0
events’’ in both arms with risk difference effect measure
did not change the direction nor the magnitude of the effect:
0.04 (0.06 to 0.02; P<.001; I2 ¼ 64%; Figure E8).
Additionally performed sensitivity subgroup analysis strat-
ified by the operative technique (PP vs posterior pericar-
dium chest tube vs both) did not reveal any between
subgroup interaction and indirectly demonstrated that there
were no differences between the approaches to posterior
pericardial drainage. (Pint ¼ 0.42; Figure E9). There was
no sign of ‘‘big-study effect’’ in the influence analysis per-
formed by deleting studies, one in a turn, and repeating the
calculations for the primary endpoint (Figure E10). Simi-
larly, exclusion of studies not reporting the exactardiovascular Surgery c Volume-, Number- 7
FIGURE 5. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for prevention of postoperative atrial
fibrillation after heart surgery. IV, Inverse variance; CI, confidence interval.
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not alter the final estimates.
DISCUSSION
The current systematic review and meta-analysis of
RCTs is the largest database that analyzes the potential
beneficial value of a posterior pericardial drainage after
heart surgery. The principle finding is the high effectiveness
of posterior pericardial drainage in preventing early and late
pericardial effusions, cardiac tamponade, and possibly mor-
tality without compromising safety. Posterior pericardial
drainage, whether performed by PP, a chest tube to posterior
pericardium, or both PP and a chest tube, was demonstrated
to (1) significantly reduce the odds of primary endpoint 30-
day cardiac tamponade by nearly 90%; (2) significantly
reduce the odds of early and late pericardial effusions by
80% and 95%, respectively; (3) significantly reduce the
odds of POAF by almost 60%; and (4) significantly shorten
the length of hospital stay. In addition, the present meta-
analysis with 19 RCTs and 3425 patients is able to demon-
strate significantly reduced odds of death or cardiac arrest.
A statistical trend towards lesser odds of AKI was shown as
well. Although there were no differences regarding the total
volume of chest tube drainage, more pleural effusions
(requiring intervention or not) were reported in the inter-
vention arm; this, however, did not translate into a greater
incidence of pulmonary complications compared with con-
trol group.
Delayed-onset pericardial effusion after heart surgery
may produce significant morbidity as the result of its pre-
sentation as well as management by traditional surgical
techniques not uncommonly involving resternotomy. The8 The Journal of Thoracic and Cardiovascular Surgerpericardial fluid collected in a gap in front of the heart usu-
ally is drained easily via a chest drain just behind the ster-
num. In contrast, pericardial adhesions frequently are
observed between the inferior and posterior surfaces of
the heart and the diaphragm that in turn may create an en-
closed gap that makes drainage difficult. The use of pericar-
diotomy technique enables better drainage of the pericardial
fluid and prevents the formation of effusion or tamponade.
Typically, PP is performed as a longitudinal, 4-cm long inci-
sion parallel and posterior to the phrenic nerve, extending
from left inferior pulmonary vein to the diaphragm.38
This allows unobstructed drainage of the blood and fluids
from the pericardium directly to the pleural space. PP is
easy to perform and it is cost-effective. Compared with a
simple chest tube drainage, however, PP may not be entirely
free from intervention-related complications; in addition to
a potential risk of cardiac herniation, PP also may exert
some adverse influence on bypass grafts as a result of
compression by pericardiotomy edges11,39 or bleeding
from the incision site.37 These complications may be mini-
mized by performing a limited PP at the end of the proced-
ure at a distance from the bypass grafts.
Meta-analyses of studies conducted so far are not conclu-
sive regarding the prevention of cardiac tamponade, and
guidelines recommendations are still weak with regard to
routine posterior pericardial drainage.8-10 Although
partially reflecting the findings of previous reports7,40 as
of reduction of the incidence of POAF, the current meta-
analysis with 19 RCTs and 3425 patients represents the
most robust data source suggesting significantly reduced
odds of cardiac tamponade after posterior pericardial
drainage. It represents a good report to show consistenty c- 2017
FIGURE 6. Subgroup analysis conducted for the primary endpoint cardiac tamponade stratified by patients’ baseline- and procedural characteristics (age,
sex, hypertension, diabetes, type of surgery, number of grafts, duration of CPB and crossclamp, and number of patients within the study). OR, Odds ratio;
95% CI, 95% confidence interval; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; X-clamp, crossclamp.
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characteristics. In addition, this study is the first to suggest
that benefit in terms of reduced incidence of cardiac tampo-
nade translated into lower odds of mortality or cardiac
arrest.
Several mechanisms are speculated to predispose to
POAF. Among them is a hypothesis that a certain amount
of fluid/hematoma into the pericardiummay represent a me-
chanical irritating stimulus to the atria, whose function can
be affected by external compression. In the first prospective
study designed to assess safety and effectiveness of PP in
reduction of the incidence of pericardial effusion and,
consequently, reducing the incidence of supraventricular ar-
rhythmias in the postoperative period, Mulay and col-
leagues38 reported the incidence of pericardial effusion in
4 of 50 patients after a PP, whereas effusion occurred in
20 of 50 patients in whom a pericardiotomy was not created
(P< .0005). The following studies have confirmed these
findings; a randomized study by Kuralay and colleagues35
showed statistically significant difference in both early (1
vs 54 patients; P < .001) and late pericardial effusion
(defined as occurring more than 30 days after operation)The Journal of Thoracic and C(0 vs 21 patients; P<.001). In addition, nearly half (10 of
21) of the patients presenting with delayed pericardial effu-
sion developed pericardial tamponade (P ¼ .01).
Because of the limited size and thus statistical power of
the next studies to come, several meta-analyses have
addressed the efficacy of PP and development of both
arrhythmias and pericardial effusion. Biancari and
colleagues,41 in a meta-analysis of 6 RCTs reporting on
POAF in 763 patients after CABG, demonstrated that the
cumulative incidence of atrial fibrillation was 10.8% in
the PP and 28.1% in the control group (OR, 0.33; 95%
CI, 0.16-0.69]; P ¼ .003). To our knowledge, the most
recent meta-analysis42 available, including 10 RCTs and
1648 patients, reported the cumulative incidence of atrial
fibrillation of 10.6% in the PP and 24.9% in the control
group, respectively (OR, 0.36; 95% CI, 0.23-0.56;
P<.001).
A present meta-analysis corroborates previous findings
on a larger scale; probably as the result of more extensive
and systematic search and no publication language restric-
tions, 17 RCTs with more than 3200 patients were included
for the analysis of POAF; odds were significantly reduced inardiovascular Surgery c Volume-, Number- 9
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compared with controls by 58%: 0.42 (0.29-0.59);
P< .001. A moderate heterogeneity observed was most
probably due to different definitions and time frames
required for a definitive diagnosis of POAF in patients after
heart surgery.
In the present meta-analysis, we assessed safety and effi-
cacy of posterior pericardial drainage compared with con-
trol regardless whether it was performed by PP, chest tube
to posterior pericardium, or both PP and a chest tube. A
number of surgeons do routinely place a posterior pericar-
dial tube (usually soft flexible rubber tube) in addition to
an anterior mediastinal tube in the same time avoiding po-
tential risk of PP-related complications. Yet, no consensus
exists on the required duration of such drainage27,30 and
its efficacy in preventing particularly delayed cardiac
tamponade. In a subgroup analysis stratified by operative
technique, we demonstrated that there were no
statistically significant differences between the technical
approaches to posterior pericardial drainage in regard to
the risk of primary endpoint. Such an indirect comparison
was, however, not the principal objective of the current
investigation.
Limitations
Several shortcoming of the current analysis should be
acknowledged. First, the present analysis shares also the
limitations of original studies. The results were therefore
analyzed on a trial and not patient level. Given heterogene-
ity in the study protocols, clinically relevant differences
could have been missed and would have been better as-
sessed in a meta-analysis of individual patient data. Second,
the present meta-analysis is limited by inclusion of studies
that, although randomized, are of suboptimal methodolog-
ical quality. Indeed, none of the studies provided a detailed
randomization protocol. Same uncertainty applies to
randomization concealment and incomplete outcome data
reporting. Although the vast majority of included studies re-
ported in-hospital mortality, only 5 reported the incidence
of neurologic complications, which are essential in studies
directed at reducing the incidence of POAF. More impor-
tantly, baseline drugs, for instance, oral anticoagulants, an-
tiplatelet therapies, antiarrhythmic drugs, or prophylaxis for
atrial fibrillation in early postoperative period, were seldom
reported. Small number of studies available for inclusion
along with small number of participants poses another lim-
itation; indeed, the largest study analyzed included only 458
patients, and 6 studies included 100 or fewer patients. We
accounted for bias and excluded studies at high risk in the
sensitivity analysis for the primary endpoint.
CONCLUSIONS
Posterior pericardial drainage is technically easy to
perform and represents a safe and effective technique that10 The Journal of Thoracic and Cardiovascular Surgesignificantly reduces not only the prevalence of early peri-
cardial effusion and related POAF but also delayed pericar-
dial effusion and cardiac tamponade. These benefits, in turn,
translate into lower odds of AKI and improved survival after
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FIGURE E1. Publication bias analysis. Funnel plots constructed for studies included in the meta-analysis for the following investigated endpoints:
A, cardiac tamponade; B, death or cardiac arrest; C, early pericardial effusion; D, late pericardial effusion; E, postoperative atrial fibrillation; F, pleural
effusion with or without intervention; G, pulmonary complications; H, reoperation for bleeding.
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FIGURE E2. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for the total chest drainage volume
expressed as mean difference and 95% CIs. SD, Standard deviation; IV, inverse variance; CI, confidence interval.
Gozdek et al AcquiredFIGURE E3. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for the incidence of pleural effusion
with or without intervention after heart surgery. M-H, Mantel-Haenszel; CI, confidence interval.
FIGURE E4. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for the prevention of pulmonary
complications after heart surgery. M-H, Mantel-Haenszel; CI, confidence interval.
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FIGURE E5. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for the incidence of reoperation for
bleeding after heart surgery. M-H, Mantel-Haenszel; CI, confidence interval.
FIGURE E6. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for prevention of acute kidney injury
after heart surgery. CI, Confidence interval.
FIGURE E7. Forest plot of the comparison between posterior pericardial drainage (intervention) and control group for the length of ICU stay (A) and
overall length of hospital stay (B) expressed as mean difference and 95% CIs. SD, Standard deviation; IV, inverse variance; CI, confidence interval.
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FIGURE E8. Sensitivity analysis conducted for the primary endpoint after accounting for studies reporting 0 events. The individual and overall estimates
are expressed as risk difference and 95% CIs. M-H, Mantel-Haenszel; CI, confidence interval.
Gozdek et al AcquiredFIGURE E9. Sensitivity subgroup analysis for the comparison between posterior pericardial drainage (intervention) and control group stratified by
operative technique conducted for the primary endpoint. The added total number of patients is greater than 3425 because of exact same control groups
in one study.30 IV, Inverse variance; CI, confidence interval.
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FIGURE E10. Sensitivity analysis (influence analysis) for the primary endpoint conducted by deleting each study at a time and repeating the calculations.
Analysis shows that no single study has influenced the overall effect of the intervention. CI, Confidence interval.
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TABLE E1. PRISMA checklist
Section/topic No. Checklist item Reported on page no.
Title
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
Abstract
Structured summary 2 Provide a structured summary including, as applicable: background;
objectives; data sources; study eligibility criteria, participants, and
interventions; study appraisal and synthesis methods; results; limitations;
conclusions and implications of key findings; systematic review
registration number.
3
Introduction
Rationale 3 Describe the rationale for the review in the context of what is already known. 5
Objectives 4 Provide an explicit statement of questions being addressed with reference to
PICOS.
5,6
Methods
Protocol and registration 5 Indicate whether a review protocol exists, if and where it can be accessed
(eg, Web address), and, if available, provide registration information
including registration number.
NA
Eligibility criteria 6 Specify study characteristics (eg, PICOS, length of follow-up) and report
characteristics (eg, years considered, language, publication status)
used as criteria for eligibility, giving rationale.
6-7
Information sources 7 Describe all information sources (eg, databases with dates of coverage,
contact with study authors to identify additional studies) in the search
and date last searched.
6-7
Search 8 Present full electronic search strategy for at least one database, including
any limits used, such that it could be repeated.
6-7, Appendix
Study selection 9 State the process for selecting studies (ie, screening, eligibility, included in
systematic review, and, if applicable, included in the meta-analysis).
6-7, Figure 1
Data collection process 10 Describe method of data extraction from reports (eg, piloted forms,
independently, in duplicate) and any processes for obtaining and
confirming data from investigators.
6-7
Data items 11 List and define all variables for which data were sought (eg, PICOS, funding
sources) and any assumptions and simplifications made.
6-8
Risk of bias in individual studies 12 Describe methods used for assessing risk of bias of individual studies
(including specification of whether this was done at the study or
outcome level), and how this information is to be used in any data
synthesis.
6-7
Summary measures 13 State the principal summary measures (eg, risk ratio, difference in means). 8-9
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if
done, including measures of consistency (eg, I2) for each meta-
analysis.
8-9
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative
evidence (eg, publication bias, selective reporting within studies).
9
Additional analyses 16 Describe methods of additional analyses (eg, sensitivity or subgroup
analyses, meta-regression), if done, indicating which were pre-specified.
9
Results
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in
the review, with reasons for exclusions at each stage, ideally with a flow
diagram.
9-10, Figure 1
Study characteristics 18 For each study, present characteristics for which data were extracted (eg,
study size, PICOS, follow-up period) and provide the citations.
9-10
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level
assessment (see item 12).
Appendix
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a)
simple summary data for each intervention group (b) effect estimates
and confidence intervals, ideally with a forest plot.
11-13, Figures 2-5
(Continued)
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TABLE E1. Continued
Section/topic No. Checklist item Reported on page no.
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals
and measures of consistency.
11-13, Figures 2-5
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). Appendix
Additional analysis 23 Give results of additional analyses, if done (eg, sensitivity or subgroup
analyses, meta-regression [see Item 16]).
13, Appendix
Discussion
Summary of evidence 24 Summarize the main findings including the strength of evidence for each
main outcome; consider their relevance to key groups (eg, healthcare
providers, users, and policy makers).
13,14
Limitations 25 Discuss limitations at study and outcome level (eg, risk of bias), and at
review-level (eg, incomplete retrieval of identified research, reporting
bias).
16-17
Conclusions 26 Provide a general interpretation of the results in the context of other
evidence, and implications for future research.
13-17
Funding
Funding 27 Describe sources of funding for the systematic review and other support (eg,
supply of data); role of funders for the systematic review.
17
PRISMA, Preferred Reporting Items for Systematic Reviews andMeta-Analyses; PICOS, participants, interventions, comparisons, outcomes, and study design. Moher D, Liberati
A, Tetzlaff J, Altman DG, The PRISMAGroup. Preferred Reporting Items for Systematic Reviews andMeta-Analyses: the PRISMA statement. PLoSMed. 2009;6(7): e1000097.
http://dx.doi.org/10.1371/journal.pmed1000097. For more information, visit: www.prisma-statement.org.
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QTABLE E2. Medline search strategy
Search Query Items found
1 Pericardiotomy 2249
2 Pericardiotomy AND randomized 62
3 Pericardial incision 405
4 Pericardial incision AND randomized 24
5 Pericardial window 760
6 Pericardial window AND randomized 6
7 Posterior pericardiotomy 73
8 Posterior pericardiotomy AND randomized 22
9 Pericardial drainage 2222
10 Pericardial drainage AND randomized 57
11 Posterior pericardium drainage 34
12 Posterior pericardium drainage AND randomized 2
13 Posterior pericardial chest tube 10
14 Posterior pericardial chest tube AND randomized 1
15 Additional chest tube 480
16 Additional chest tube AND randomized 57
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TABLE E3. Exclusion criteria and institutional review board approval
Study Exclusion criteria IRB approval
Arbatli and colleagues19 Renal dysfunction, LV aneurysm, severe LV dysfunction, MR, evident COPD, history of AF,
endocrine disorders, b-blocker therapy end dense adhesion inside the pericardium or left
pleural cavity
NR
Asimakopoulos and colleagues20 Not specified NR
Bakhshandeh and colleagues21,22 Not specified NR
Bolourian and colleagues23 Severe LV dysfunction with LVEF<25%, history of AF, concomitant valvular disease,
‘‘abnormal’’ left atrial dimensions (NS); participation in another study.
Yes
Cakalagaoglu and colleagues24 Re-do cases, left-sided pleural adhesions, arrhythmias, in particular AF, documented
depression and anxiety, hyperthyroidism, LV aneurysm, renal failure (plasma creatinine
>2.0 mg/dL), use of b-blocker, and inability to provide informed consent because of a
neurologic or psychiatric illness
Yes
Ekim and colleagues25 Hyperthyroidism, COPD, renal dysfunction, LV aneurysm, severe LV dysfunction, history of
AF, previous CABG, concomitant valvular disease, dense adhesion of the lung, b-blocker
therapy
NR
Erdil and colleagues26 CAD Yes
Eryilmaz and colleagues27 Re-do cases, CAD requiring CABG, any form of anticoagulation before surgical intervention, a
second operative procedure (apart from bleeding or tamponade) during the same hospital
stay
Yes
Farsak and colleagues11 Hyperthyroidism, COPD, renal dysfunction, LVaneurysm, valvular heart disease, preoperative
AF, and b-blocker therapy
NR
Fawzy and colleagues28 Previous AF or antiarrhythmic drugs therapy, severe LV dysfunction (LVEF 30%), COPD,
renal impairment, hyperthyroidism, redo and emergency CABG, combined cardiac
procedures
Yes
Haddadzadeh and colleagues29 Cardiac arrhythmia, pericardial effusion, electrolyte or hemodynamic disturbances, previous
CABG, and valvular repair
Yes
Kaya and colleagues30 Renal failure, hyperthyroidism, emergency coronary artery surgery, history of cardiac
operations associated with valvular heart disease, LVEF<35%, and preoperative AF or other
rhythm disorders, no consent
Yes
Kaya and colleagues31 P2Y12 inhibitor therapy, valve regurgitation, kidney failure, hyper- and or hypothyroidism,
emergency or re-do cases, preoperative rhythm disorders, patients with pacemakers, and
OPCAB
Yes
Kaya and colleagues32 Renal insufficiency, concomitant valve surgery, emergency surgery, preoperative AF, and redo
cases
NR
Kaygin and colleagues33 Renal failure, ventricular arrhythmias; LV aneurysm, COPD, severe LV dysfunction,
hyperthyroidism, valvular heart disease, bleeding disorders, patients with rhythm problems
and valvular pathologies on OAC; more than 2 chest tubes, and those who required
concomitant surgery.
Yes
Kongmalai and colleagues34 Not specified NR
Kuralay and colleagues35 Hyperthyroidism, COPD, renal dysfunction, LV aneurysm, severe LV dysfunction, combined
valvular heart disease, b-blocker therapy
NR
Sadeghpour and colleagues36 Coagulation disorder, renal and hepatic insufficiency, re-do cases, and OAC NR
Zhao and colleagues37 Re-do cases, paroxysmal AF, preoperative coagulant disorders that could have influenced the
postoperative results, asthma, and hepatic or renal dysfunction
Yes
LV, Left ventricular;MR, mitral regurgitation; COPD, chronic obstructive pulmonary disease; AF, atrial fibrillation; NR, not reported; LVEF, left ventricle ejection fraction; NS,
not specified; CABG, coronary artery bypass grafting; CAD, coronary artery disease; OPCAB, off-pump coronary artery bypass graft; OAC, oral anticoagulation.
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TABLE E4. Endpoint definitions
Study
Cardiac tamponade
(definition;
diagnostic criteria) Pericardial effusion criteria Early effusion Late effusion Postoperative AF
Arbatli and colleagues19 Not defined; NS minimal 0-50 mL, mild 50-100 mL,
moderate 100-500 mL,
severe>500 mL
Not defined Not defined AF sustained<15 min
Asimakopoulos
and colleagues20
Not defined; NS NR NR NR Not defined
Bakhshandeh
and colleagues21,22
Not defined; NS Echo-free space in diastole, small
<10mm,moderate>10 to<20mm
posteriorly, large>20 mm, very
large>20 mm, and compression of
the heart
<30 d after surgery >30 d after
surgery
Not defined
Bolourian and
colleagues23
Not defined; NS NR NR NR NR
Cakalagaoglu and
colleagues24
Not defined; NS Echo-free space in diastole, small
<10 mm, moderate>10 to<20
posteriorly, large>20 mm, very
large>20 mm, and compression of
the heart
Before discharge 15 d after
surgery
AF or atrial
flutter>20 min
Ekim and colleagues25 Not defined;
hemodynamic
data and/or the
echocardiographic
findings
Maximum diastolic separation
between pericardium and
epicardiummeasured at the level of
the tip of the mitral valve leaflet.
Any effusion>1 cm was
considered significant
Not defined Not defined AF or atrial
flutter>20 min
Erdil and colleagues26 Hemodynamic
data and/or the
echocardiographic
findings
Maximum diastolic separation
between pericardium and
epicardiummeasured at the level of
the tip of the mitral valve leaflet.
Any effusion>1 cm was
considered significant
<24 h 5-7 d after
surgery
NR
Eryilmaz and
colleagues27
Not defined; NS Effusion 10 mm were considered
significant
first postoperative
week
after the
first week
NR
Farsak and
colleagues11
Not defined; NS Maximum diastolic separation
between pericardium and
epicardiummeasured at the level of
the tip of the mitral valve leaflet.
Any effusion>1 cm was
considered significant
<30 d after surgery 30 d after
surgery
NR
Fawzy and colleagues28 Not defined; NS Effusion 10 mm were considered
significant
Not defined Not defined AF or atrial flutter
>30 min even after
correction of hypoxia
and electrolyte
imbalance
Haddadzadeh
and colleagues29
Not defined; NS Effusion 10 mm were considered
significant
NR NR AF or atrial flutter
>30 min
Kaya and colleagues30 Clinical signs and
symptoms in
addition to
echocardiographic
criteria
Echo-free space in diastole, small
<10mm,moderate>10 to<20mm
posteriorly, large>20 mm, very
large>20 mm, and compression of
the heart
<30 d after surgery 30 d after
surgery
AF or atrial flutter
>5 min
Kaya and colleagues31 Not defined; NS Echo-free space in diastole, small
<10 mm, moderate>10 to<20
posteriorly, large>20 mm, very
Not defined Not defined Presence of irregular
ventricular rate and
absence of consistent
P-waves before each
(Continued)
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TABLE E4. Continued
Study
Cardiac tamponade
(definition;
diagnostic criteria) Pericardial effusion criteria Early effusion Late effusion Postoperative AF
large>20 mm, and compression of
the heart
QRS complex;
persistence
not specified
Kaya and colleagues32 Not defined; NS Echo-free space in diastole, small
<10mm,moderate>10 to<20mm
posteriorly, large>20 mm, very
large>2 mm, and compression of
the heart
Not defined Not defined Absence of consistent
P waves before each
QRS complex and an
irregular ventricular
rate; persistence not
specified
Kaygin and colleagues33 Not defined; NS Any effusion between the epicardial
and pericardial surfaces>1 cm in
echocardiogram image was
considered as significant
Before discharge 1 mo after
discharge
Not defined; persistence
not specified
Kongmalai and
colleagues34
Not defined; NS Not defined Not defined Not defined Not defined
Kuralay and
colleagues35
Hemodynamic
data and the
echocardiographic
findings
Maximum diastolic separation
between pericardium and
epicardiummeasured at the level of
the tip of the mitral valve leaflet.
Any effusion>1 cm was
considered significant
<30 d after surgery 30 d after
surgery
AF or atrial flutter
>30 min
Sadeghpour and
colleagues36
Not defined; NS Not defined; NS <3 d after surgery >3 d after
surgery
Not defined
Zhao and colleagues37 Not defined; NS <10 mm, localized in posterior
pericardial cavity, small 10–
20 mm, involving anterior wall of
right ventricle, moderate>20 mm,
circumferential effusion, large
Not defined, NS effusion
measured at 10 postoperative day
Not defined; persistence
not specified
AF, Atrial fibrillation; NS, not specified; NR, not reported.
Gozdek et al Acquired
A
C
QThe Journal of Thoracic and Cardiovascular Surgery c Volume-, Number- 11.e10
TABLE E5. Chest drainage and posterior pericardiotomy technique
Study Chest drainage technique Posterior pericardiotomy technique
Arbatli and colleagues19 Two drains in both groups. One in the left pleural cavity
and the other in the anterior mediastinum. Lower part
of the pericardium left open.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Asimakopoulos and colleagues20 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Bakhshandeh and colleagues21,22 NR A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein toward the inferior vena cava and
diaphragm.
Bolourian and colleagues23 NR Incision along the posterior length of left phrenic nerve,
4-6 cm long, extending from left inferior pulmonary
vein to the diaphragm.
Cakalagaoglu and colleagues24 Two drains in study and control group in CABG cases:
one in the left pleural cavity and the other in the
anterior mediastinum. Two drains in study and control
group in valve cases: anterior mediastinum (or 3 when
left pleural cavity was opened). Pericardium left open
anteriorly.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Ekim and colleagues25 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Erdil and colleagues26 Two drains in study group, one in the left pleural cavity
and the other in the anterior mediastinum. One drain in
the control group positioned in the anterior
mediastinum.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Eryilmaz and colleagues27 Two drains in study group, one in the anterior
mediastinum and the other (thin closed-suction drain
system) behind the heart. One drain in control group:
anterior mediastinum plus another drain in both group
when left or right pleura was opened.
NA
Farsak and colleagues11 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum. Pericardium
left open anteriorly.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Fawzy and colleagues28 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum. Pericardium
left open anteriorly.
A longitudinal, 4-cm long and 2-cm wide incision
parallel and posterior to the phrenic nerve, extending
from left inferior pulmonary vein to the diaphragm.
Haddadzadeh and colleagues29 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum. Pericardium
left open anteriorly.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Kaya and colleagues30 Two or three drains in study group. One in the left pleural
cavity and the other in the anterior mediastinum. Third
drain in 33 patients positioned behind the heart. Two
drains in control group, one in the left pleural cavity
and the other in the anterior mediastinum. Pericardium
left open (2 cm).
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm. The left pleural
cavity was opened.
Kaya and colleagues31 Three drains in study group, one in the left pleural cavity,
one in the anterior mediastinum and the other in the
pericardial sac along the right atrium. Pericardiumwas
closed. Two drains in control group. Left pleural
cavity and anterior mediastinum. Pericardium left
open (2 cm).
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
(Continued)
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TABLE E5. Continued
Study Chest drainage technique Posterior pericardiotomy technique
Kaya and colleagues32 Three drains in study group, one in the left pleural cavity,
one in the anterior mediastinum and the other in the
pericardial sac along the right atrium. Proximal
anastomoses of the bypass grafts and nearly half of the
anterior surface of the heart were covered by
pericardium. Two drains in control group: left pleural
cavity and anterior mediastinum.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Kaygin and colleagues33 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum. Pericardium
left open anteriorly.
A circular, 4-cm long incision parallel and posterior to
the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Kongmalai and colleagues34 NR NR
Kuralay and colleagues35 Two drains in both groups, one in the left pleural cavity
and the other in the anterior mediastinum. Pericardium
left open anteriorly.
A longitudinal, 4-cm long incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Sadeghpour and colleagues36 NR A longitudinal, 4 cm long, incision parallel and posterior
to the phrenic nerve, extending from left inferior
pulmonary vein to the diaphragm.
Zhao and colleagues37 Two or three drains in study group, one in the left or both
pleural cavities, one in the anterior mediastinum. Two
drains in control group, one in the pericardial sac along
the right atrium and the other in the anterior
mediastinum.
Inverse T, 2.5 cm long in both dimensions (left, right, or
bilateral window) incision, parallel and posterior to
the phrenic nerve, extending from inferior pulmonary
vein to the diaphragm.
NR, Not reported; CABG, coronary artery bypass grafting; NA, not applicable.
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Study
Random
sequence
generation
(selection
bias)
Allocation
concealment
(selection
bias)
Blinding of
participants
and
personnel
(performance
bias)
Blinding of
outcome
assessment
(detection
bias)
Incomplete
outcome
data (attrition
bias)
Selective
reporting
(reporting bias)
Other
bias
Jadad
score
Arbatli and colleagues19     þ þ þ 2
Asimakopoulos and colleagues20     þ þ þ 1
Bakhshandeh and colleagues21,22      þ þ 1
Bolourian and colleagues23       þ 1
Cakalagaoglu and colleagues24     þ þ þ 2
Ekim and colleagues25     þ þ þ 2
Erdil and colleagues26 þ    þ þ þ 2
Eryilmaz and colleagues27    þ þ þ þ 2
Farsak and colleagues11 þ    þ  þ 3
Fawzy and colleagues28 þ    þ þ þ 3
Haddadzadeh and colleagues29     þ þ þ 2
Kaya and colleagues30 þ  þ þ þ þ þ 4
Kaya and colleagues31 þ þ þ  þ þ þ 5
Kaya and colleagues32 þ   þ þ þ þ 3
Kaygin and colleagues33     þ þ þ 3
Kongmalai and colleagues34     þ þ þ 1
Kuralay and colleagues35 þ    þ þ þ 3
Sadeghpour and colleagues36     þ þ þ 2
Zhao and colleagues37 þ þ   þ þ þ 3
Cohen’s kappa 0.89 0.84 0.79 0.84 0.84 0.89 0.84
, Unclear risk of bias; , high risk of bias; þ, low risk of bias.
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Posterior pericardial drainage was found to reduce postoperative complications, such as cardiac
tamponade and atrial fibrillation, among others. In addition, it improved survival after heart
surgery.The Journal of Thoracic and Cardiovascular Surgery c- 2017
